Skip to content

Hadis Nasoori

Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

2 papers in the library · 27 citations · publishing 2024-2025

Papers

Features of biliary tract diseases in ketamine abusers: a systematic review of case reports.

Journal of medical case reports March 3, 2024 Alireza Teymouri, Hadis Nasoori, Maryamsadat Fakheri et al. 20 citations

Ketamine abuse can cause damage to the bile ducts and liver, a condition known as cholangiopathy. A systematic review of case reports found that affected patients are typically young men around 26 years old, presenting with abdominal pain, nausea, and vomiting. Imaging often shows dilation of the common bile duct. Most patients improve with supportive care, but the condition requires a multidisciplinary management approach. The review highlights the need to consider ketamine abuse in young patients with unexplained biliary symptoms and abnormal liver function.

Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.

Molecular neurobiology June 4, 2025 Naser-Aldin Lashgari, Mahla Khalaji, Pouria Rana et al. 7 citations

Psychedelic compounds such as LSD, psilocybin, MDMA, DMT, and ketamine show therapeutic potential for neurological and psychiatric disorders including depression, PTSD, Alzheimer's disease, and Parkinson's disease. Their benefits arise from multiple mechanisms: anti-inflammatory effects (reducing cytokines like IL-6 and TNF-α), antioxidant activity (inducing SOD), and enhancing neuroplasticity via increased BDNF expression. They also modulate serotonin and dopamine systems. Compared to conventional treatments, psychedelics offer faster onset, longer-lasting effects, and possible disease-modifying properties, making them promising candidates for future therapies.